Single-Dose Versus Multiple-Dose Prophylactic Antibiotics in Minimally Invasive Colorectal Surgery: A Propensity

Ga Yoon Ku1,2, Beom-Jin Kim1, Ji Won Park1,2,3

  • 1Department of Surgery, Seoul National University Hospital, Seoul, Korea.

PubMed
Abstract

Insights

A single preoperative dose of prophylactic antibiotics is sufficient for preventing surgical site infections (SSIs) in minimally invasive colorectal cancer surgery, aligning with current guidelines and reducing unnecessary antibiotic use.

Area of Science:

  • Colorectal Surgery
  • Infectious Disease Prevention
  • Surgical Oncology

Background:

  • Current guidelines suggest stopping prophylactic antibiotics post-surgery to prevent surgical site infections (SSIs).
  • Many colorectal surgeons continue prolonged antibiotic use, despite guidelines.
  • Limited research exists on optimal prophylactic antibiotic dosing for minimally invasive colorectal surgery.

Purpose of the Study:

  • To compare the efficacy of single-dose versus multiple-dose prophylactic antibiotics in preventing SSIs after minimally invasive colorectal cancer surgery.
  • To identify risk factors for SSIs in this patient population.

Main Methods:

  • Retrospective study of patients undergoing elective minimally invasive colorectal cancer surgery.
  • Comparison of SSI rates between a single preoperative dose group and a multiple-dose (preoperative plus within 24 hours post-op) group.
  • Propensity score matching (PSM) and multivariable analysis were used to control for confounding factors and identify SSI risk factors.

Main Results:

  • No significant difference in SSI rates was observed between single-dose and multiple-dose groups, both before and after PSM.
  • Multivariable analysis identified ASA class 3, rectal surgery, intraoperative transfusion, and larger tumor size as independent risk factors for SSIs.
  • Length of hospital stay was the only outcome that differed between the groups.

Conclusions:

  • A single preoperative dose of prophylactic antibiotics appears adequate for preventing SSIs in elective minimally invasive colorectal cancer surgery.
  • This finding supports de-escalation of antibiotic therapy in this surgical context.
  • Risk stratification for SSIs should consider factors like patient comorbidities, surgical site, and intraoperative events.